| Net Cash Provided by (Used in) Operating Activities |
$1,530,000 |
USD |
-13% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,069,000 |
USD |
-6.8% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,931,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
40,584,766 |
shares |
28% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$332,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$2,847,000 |
USD |
22% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$33,123,000 |
USD |
5.7% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$33,123,000 |
USD |
5.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$319,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$526,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$40,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$40,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$207,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$40,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$19,958,000 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$40,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$302,329,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$2,400,000 |
USD |
200% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$2,081,000 |
USD |
-0.57% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$3,300,000 |
USD |
-38% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$2,979,000 |
USD |
-17% |
Q1 2024 |
Q1 2024 |